预防性抗生素方案与种植牙失败:系统综述与荟萃分析
该系统综述与荟萃分析纳入8项RCT(1585例患者、2869枚种植体),评估健康患者预防性抗生素(AP)及不同方案对种植失败的影响。荟萃分析显示AP可显著降低种植失败数,但个体试验差异不显著且存在混杂因素,结论尚不确定,不建议健康种牙患者 indiscriminate 使用抗生素。
要点
- AP合并方案可显著降低种植失败数(种植体P=.005;患者P=.002)。
- 术前、术前+术后、仅术后AP均与无抗生素相比有显著差异。
- 个体试验差异不显著且存在混杂,结论尚不确定。
核心结论
- 荟萃分析提示AP可能降低种植失败,但尚不能得出确定性结论。
- 健康种牙患者不应 indiscriminate 使用抗生素,需权衡感染结局与抗生素风险。
研究设计与样本
- 系统综述与荟萃分析,检索电子数据库并手工检索随机对照试验(RCT)。
- 最终纳入8项RCT,共1585例患者、2869枚种植体。
- 使用Cochrane手册评估偏倚风险,采用随机效应模型分析二分类数据风险比。
主要发现
- AP所有方案合并与无抗生素相比,种植失败数显著降低(种植体P=.005;患者P=.002)。
- 术前AP与无抗生素相比,种植失败数显著降低(种植体P=.01;患者P=.007)。
- 术前+术后AP与无抗生素相比,种植失败数显著降低(种植体P=.04)。
- 仅术后AP与无抗生素相比,种植失败数显著降低(种植体P=.02)。
- 比较不同抗生素方案及次要结局(种植体周围黏膜炎/种植体炎、修复失败、不良事件)均无显著差异。
临床怎么用
- 不应仅凭荟萃分析结果对健康种牙患者常规 indiscriminate 使用预防性抗生素。
- 需结合个体试验差异、混杂因素、种植感染结局及抗生素相关风险综合决策。
局限性
- 个体试验中总体差异不显著,且存在所讨论的局限性。
- 存在混杂变量,影响结果解释。
- 尚需大规模RCT排除混杂因素以确定AP及不同方案的疗效。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In this systematic review and meta-analysis, the authors examine the efficacy of antibiotic prophylaxis (AP) and specific antibiotic regimens for prevention of dental implant failure in patients who are healthy overall. TYPES OF STUDIES REVIEWED: The authors independently conducted electronic database and manual searches to identify randomized controlled trials (RCTs). The authors selected articles on the basis of eligibility criteria and assessed for risk of bias by using the Cochrane Handbook. Implant failure was the primary outcome studied; perimucositis or implantitis, prosthetic failure, and adverse events were secondary outcomes studied. The authors conducted random effects meta-analysis for risk ratios of dichotomous data and used OpenMeta[Analyst] (Center for Evidence Synthesis, Brown School of Public Health) for qualitative assessment of administration schedules. RESULTS: With duplicates removed, the authors screened 1,022 abstracts, reviewed 21 full-text articles, and included 8 RCTs that included 2,869 implants in 1,585 patients. Meta-analysis results indicated that AP resulted in a statistically significantly lower number of implant failures for all regimens combined (implant, P = .005; patient, P = .002), as well as preoperative (implant, P = .01; patient, P = .007), pre- and postoperative (implant, P = .04), and postoperative AP only (implant, P = .02), compared with no antibiotics. The authors found no statistically significant differences in analysis of comparative antibiotic treatments or secondary outcomes. The authors identified confounding variables. CONCLUSIONS AND PRACTICAL IMPLICATIONS: Although meta-analysis results suggested that AP may reduce implant failure, definitive conclusions cannot be achieved yet. The overall nonsignificant differences reported in individual trials, limitations discussed, implant infection outcomes, and antibiotic-associated risks must be considered. Thus, the results for implant failure outcomes may not warrant the indiscriminate use of antibiotics in patients who are healthy who are receiving dental implants. Investigators must conduct large-scale RCTs to determine the efficacy of AP and various regimens, independent of confounding variables.
引用
- Braun RS, Chambrone L, Khouly I, et al. Prophylactic antibiotic regimens in dental implant failure: A systematic review and meta-analysis. J Am Dent Assoc. 2019. PMID: 31010572. doi:10.1016/j.adaj.2018.10.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。